Variant report
Variant | nsv521942 |
---|---|
Chromosome Location | chr3:22123064-22139499 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:22130685..22131408-chr3:22159081..22159858,3 | MCF-7 | breast: | |
2 | chr3:22130650..22131348-chr3:22159010..22159875,2 | MCF-7 | breast: | |
3 | chr3:22127371..22129495-chr3:22135710..22137615,2 | K562 | blood: | |
4 | chr3:22115704..22118143-chr3:22137096..22138813,2 | MCF-7 | breast: | |
5 | chr3:22127371..22129495-chr3:22135710..22137615,2 | K562 | blood: | |
6 | chr3:22130623..22131453-chr3:22928892..22930144,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1871523 | chr3:22129829-22129830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs2170091 | chr3:22129839-22129840 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs540638849 | chr3:22129859-22129860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372142313 | chr3:22129864-22129865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563715417 | chr3:22129867-22129868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558996012 | chr3:22129873-22129874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1871522 | chr3:22129881-22129882 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs187044528 | chr3:22129932-22129933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569822704 | chr3:22129935-22129936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530665253 | chr3:22129946-22129947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552425708 | chr3:22129947-22129948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191109693 | chr3:22129982-22129983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539002756 | chr3:22129993-22129994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs566001422 | chr3:22130002-22130003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554232283 | chr3:22130017-22130018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182676048 | chr3:22130035-22130036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536754934 | chr3:22130050-22130051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186012362 | chr3:22130058-22130059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576556473 | chr3:22130099-22130100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2620543 | chr3:22130107-22130108 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs551532746 | chr3:22130109-22130110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547117819 | chr3:22130117-22130118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559168625 | chr3:22130132-22130133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57059564 | chr3:22130147-22130148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577139420 | chr3:22130183-22130184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138239573 | chr3:22130192-22130193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540577234 | chr3:22130195-22130196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200155382 | chr3:22130197-22130198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529681412 | chr3:22130234-22130235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147837620 | chr3:22130278-22130279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148905823 | chr3:22130282-22130283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116540038 | chr3:22130289-22130290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143651415 | chr3:22130311-22130312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570699559 | chr3:22130338-22130339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528399205 | chr3:22130379-22130380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151049097 | chr3:22130380-22130381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367815477 | chr3:22130382-22130383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182506915 | chr3:22130391-22130392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2695642 | chr3:22130392-22130393 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs369637534 | chr3:22130407-22130408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187365154 | chr3:22130417-22130418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191953739 | chr3:22130455-22130456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140978510 | chr3:22130478-22130479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375170661 | chr3:22130507-22130508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1965284 | chr3:22130509-22130510 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs79087205 | chr3:22130518-22130519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9832978 | chr3:22130526-22130527 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs553298805 | chr3:22130527-22130528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145074270 | chr3:22130536-22130537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138880783 | chr3:22130553-22130554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22129800-22130200 | Enhancers | Fetal Lung | lung |
2 | chr3:22129800-22130800 | Enhancers | Colon Smooth Muscle | Colon |
3 | chr3:22130600-22130800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr3:22130600-22130800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr3:22130800-22131000 | Active TSS | Hela-S3 | cervix |
6 | chr3:22130800-22131200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr3:22130800-22131200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr3:22130800-22131200 | Enhancers | Adipose Nuclei | Adipose |
9 | chr3:22130800-22132400 | Enhancers | Liver | Liver |
10 | chr3:22131000-22131200 | Enhancers | Pancreas | Pancrea |
11 | chr3:22131000-22131200 | Flanking Active TSS | Hela-S3 | cervix |
12 | chr3:22131200-22133000 | Enhancers | Hela-S3 | cervix |
13 | chr3:22132800-22133200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
14 | chr3:22133200-22133800 | Active TSS | Skeletal Muscle Male | skeletal muscle |
15 | chr3:22135000-22135400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr3:22135400-22139600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
17 | chr3:22138200-22139000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr3:22139000-22139800 | Enhancers | Hela-S3 | cervix |